ProShare Advisors’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-10,568
Closed -$273K 1984
2025
Q4
$273K Buy
10,568
+315
+3% +$7.49K ﹤0.01% 1518
2025
Q3
$264K Sell
10,253
-1,754
-15% -$43.1K ﹤0.01% 1517
2025
Q2
$287K Sell
12,007
-880
-7% -$22.2K ﹤0.01% 1470
2025
Q1
$320K Sell
12,887
-3,116
-19% -$74.6K ﹤0.01% 1366
2024
Q4
$301K Buy
16,003
+3,710
+30% +$65.1K ﹤0.01% 1630
2024
Q3
$185K Buy
12,293
+2,389
+24% +$40.8K ﹤0.01% 1753
2024
Q2
$283K Sell
9,904
-2,557
-21% -$72.8K ﹤0.01% 1330
2024
Q1
$364K Buy
12,461
+924
+8% +$28.4K ﹤0.01% 1293
2023
Q4
$389K Buy
11,537
+1,550
+16% +$45.3K ﹤0.01% 1205
2023
Q3
$306K Sell
9,987
-115
-1% -$4.14K ﹤0.01% 1198
2023
Q2
$405K Buy
10,102
+376
+4% +$15.5K ﹤0.01% 1078
2023
Q1
$397K Sell
9,726
-1,188
-11% -$47.3K ﹤0.01% 1027
2022
Q4
$421K Buy
10,914
+860
+9% +$41.8K ﹤0.01% 1043
2022
Q3
$534K Buy
10,054
+164
+2% +$9.12K ﹤0.01% 886
2022
Q2
$576K Sell
9,890
-4,585
-32% -$300K ﹤0.01% 894
2022
Q1
$1.1M Sell
14,475
-2,841
-16% -$189K ﹤0.01% 881
2021
Q4
$1.04M Buy
17,316
+1,079
+7% +$59.5K ﹤0.01% 997
2021
Q3
$909K Sell
16,237
-4,194
-21% -$242K ﹤0.01% 933
2021
Q2
$1.24M Buy
20,431
+1,710
+9% +$108K ﹤0.01% 915
2021
Q1
$1.31M Buy
18,721
+1,734
+10% +$124K ﹤0.01% 846
2020
Q4
$1.02M Buy
16,987
+4,185
+33% +$245K ﹤0.01% 874
2020
Q3
$770K Sell
12,802
-254
-2% -$14.8K ﹤0.01% 796
2020
Q2
$685K Buy
13,056
+4,237
+48% +$177K ﹤0.01% 822
2020
Q1
$296K Sell
8,819
-6,908
-44% -$287K ﹤0.01% 877
2019
Q4
$712K Sell
15,727
-1,213
-7% -$51.5K ﹤0.01% 927
2019
Q3
$645K Buy
16,940
+664
+4% +$26.5K ﹤0.01% 898
2019
Q2
$708K Sell
16,276
-2,068
-11% -$87.8K ﹤0.01% 891
2019
Q1
$698K Buy
18,344
+227
+1% +$8.86K ﹤0.01% 910
2018
Q4
$779K Sell
18,117
-3,467
-16% -$162K 0.01% 783
2018
Q3
$1.06M Sell
21,584
-1,760
-8% -$76.1K 0.01% 801
2018
Q2
$748K Sell
23,344
-1,604
-6% -$55.4K 0.01% 945
2018
Q1
$777K Sell
24,948
-3,837
-13% -$137K 0.01% 928
2017
Q4
$1.31M Buy
28,785
+2,398
+9% +$95K 0.01% 741
2017
Q3
$991K Buy
26,387
+1,495
+6% +$60.2K 0.01% 734
2017
Q2
$1.19M Sell
24,892
-63
-0.3% -$2.92K 0.01% 689
2017
Q1
$1.14M Sell
24,955
-6,144
-20% -$266K 0.01% 710
2016
Q4
$1M Buy
31,099
+2,937
+10% +$98K 0.01% 776
2016
Q3
$964K Sell
28,162
-5,195
-16% -$204K 0.01% 689
2016
Q2
$1.13M Buy
33,357
+663
+2% +$32.6K 0.01% 682
2016
Q1
$1.73M Sell
32,694
-3,545
-10% -$207K 0.02% 501
2015
Q4
$2.78M Buy
36,239
+3,477
+11% +$197K 0.03% 413
2015
Q3
$1.35M Sell
32,762
-2,942
-8% -$180K 0.02% 590
2015
Q2
$2.52M Sell
35,704
-2,262
-6% -$178K 0.03% 438
2015
Q1
$3.37M Buy
37,966
+4,583
+14% +$465K 0.04% 406
2014
Q4
$2.96M Sell
33,383
-424
-1% -$40.1K 0.03% 460
2014
Q3
$3.28M Sell
33,807
-5,214
-13% -$507K 0.04% 446
2014
Q2
$3.58M Sell
39,021
-14,698
-27% -$1.12M 0.05% 413
2014
Q1
$3.76M Buy
53,719
+36,950
+220% +$2.51M 0.05% 375
2013
Q4
$964K Sell
16,769
-12,342
-42% -$649K 0.01% 989
2013
Q3
$1.4M Buy
29,111
+10,802
+59% +$394K 0.03% 625
2013
Q2
$531K Buy
+18,309
New +$530K 0.01% 1292

Other funds holding PCRX